19-42733612-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000594378.1(PSG3):​n.*56A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 157,474 control chromosomes in the GnomAD database, including 32,683 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 31722 hom., cov: 30)
Exomes 𝑓: 0.54 ( 961 hom. )

Consequence

PSG3
ENST00000594378.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.970

Publications

2 publications found
Variant links:
Genes affected
PSG3 (HGNC:9520): (pregnancy specific beta-1-glycoprotein 3) The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy. Molecular cloning and analysis of several PSG genes has indicated that the PSGs form a subgroup of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily of genes. Members of the CEA family consist of a single N domain, with structural similarity to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constant-like A and/or B domains. Most PSGs have an arg-gly-asp (RGD) motif, which has been shown to function as an adhesion recognition signal for several integrins, in the N-terminal domain (summary by Teglund et al., 1994 [PubMed 7851896]). For additional general information about the PSG gene family, see PSG1 (MIM 176390).[supplied by OMIM, Oct 2009]
LIPE-AS1 (HGNC:48589): (LIPE antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSG3NM_021016.4 linkc.431-550A>C intron_variant Intron 2 of 6 ENST00000327495.10 NP_066296.2 Q16557
PSG3XM_011527126.3 linkc.497-550A>C intron_variant Intron 2 of 5 XP_011525428.1
PSG3XM_011527127.3 linkc.497-550A>C intron_variant Intron 2 of 4 XP_011525429.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSG3ENST00000327495.10 linkc.431-550A>C intron_variant Intron 2 of 6 1 NM_021016.4 ENSP00000332215.5 Q16557

Frequencies

GnomAD3 genomes
AF:
0.633
AC:
95628
AN:
151170
Hom.:
31664
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.840
Gnomad AMI
AF:
0.383
Gnomad AMR
AF:
0.608
Gnomad ASJ
AF:
0.546
Gnomad EAS
AF:
0.448
Gnomad SAS
AF:
0.606
Gnomad FIN
AF:
0.592
Gnomad MID
AF:
0.602
Gnomad NFE
AF:
0.545
Gnomad OTH
AF:
0.584
GnomAD4 exome
AF:
0.540
AC:
3340
AN:
6184
Hom.:
961
Cov.:
0
AF XY:
0.535
AC XY:
1716
AN XY:
3208
show subpopulations
African (AFR)
AF:
0.808
AC:
21
AN:
26
American (AMR)
AF:
0.609
AC:
1087
AN:
1786
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
14
AN:
28
East Asian (EAS)
AF:
0.398
AC:
86
AN:
216
South Asian (SAS)
AF:
0.573
AC:
379
AN:
662
European-Finnish (FIN)
AF:
0.400
AC:
16
AN:
40
Middle Eastern (MID)
AF:
0.500
AC:
2
AN:
4
European-Non Finnish (NFE)
AF:
0.509
AC:
1632
AN:
3204
Other (OTH)
AF:
0.472
AC:
103
AN:
218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
70
139
209
278
348
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.633
AC:
95750
AN:
151290
Hom.:
31722
Cov.:
30
AF XY:
0.631
AC XY:
46663
AN XY:
73908
show subpopulations
African (AFR)
AF:
0.840
AC:
34439
AN:
40990
American (AMR)
AF:
0.608
AC:
9241
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.546
AC:
1892
AN:
3466
East Asian (EAS)
AF:
0.449
AC:
2306
AN:
5138
South Asian (SAS)
AF:
0.604
AC:
2898
AN:
4796
European-Finnish (FIN)
AF:
0.592
AC:
6225
AN:
10512
Middle Eastern (MID)
AF:
0.616
AC:
180
AN:
292
European-Non Finnish (NFE)
AF:
0.545
AC:
36989
AN:
67876
Other (OTH)
AF:
0.586
AC:
1232
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1538
3075
4613
6150
7688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.606
Hom.:
4342
Bravo
AF:
0.641

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.87
DANN
Benign
0.49
PhyloP100
-0.97
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4030933; hg19: chr19-43237764; API